Exclusive Licence for a Novel Liver Function Test on Pascal

SYDNEY, 20 January, Australia, 2026 - Atomo Diagnostics Limited (ASX:AT1) (Atomo) is pleased to announce signing an exclusive global licensing agreement with the Burnet Diagnostics Initiative, part of The Macfarlane Burnet Institute for Medical Research and Public Health. The agreement remains in effect until the date of expiry of the last of all of the patents forming part of the Patent Rights, p